ClinicalTrials.gg
TerminatedNCT05034341Updated May 13, 2024

Does Prehabilitation Improve Outcomes in Patients Undergoing Complex Spine Fusion Surgery?

An interventional study of Multimodal Prehabilitation and Standard Pre-Surgical Clinical Care in Lumbar Spine Injury, Spinal Fusion and Frailty, sponsored by University of Florida. Terminated at 1 site in United States. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-05-13.

Sponsored by University of Florida · Not applicable, Interventional, and Treatment

Why this study was terminated
PI leaving institution and unable to complete study.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Study summary

A novel prehabilitation method has been implemented at our institution to decrease perioperative outcome complications for frail complex spine fusion surgery patients. The goal of this randomized trial is to evaluate whether this prehabilitation program improves preoperative functional status of frail spine disease patients and benefits patients in their postsurgical outcomes.

Read the detailed description

Background:

Patients with degenerative lumbar spine disease who are candidates for spine surgery may experience multiple adverse effects from the prolonged conservative and non-operative management of chronic low back pain. Due to the aging population, there is an increased demand for lumbar spine surgery in the geriatric population. At the time these patients are candidates for surgery, they might encounter the results of the conservative management including disabling pain, catastrophizing, and Kinesiophobia. The chronicity of the spine condition and the associated pain may result in functional disability, poor nutrition, and poor pain management, all of which may result in a multisystemic impact on their overall health in the form of frailty. Prehabilitation has been studied in the past to evaluate its impact on the postoperative outcomes for patients scheduled for abdominal surgery, cardiac surgery, and thoracic surgery. Currently, there are a few trials evaluating the impact of prehabilitation in spine surgery. However, there are limited data on the impact of prehabilitation on frail geriatric patients undergoing spine surgery and whether prehabilitation will impact frail patients' preoperative and postoperative functional recovery and pain management.

Based on the current literature, the investigator will hypothesize that prehabilitation will improve frail geriatric patients' preoperative and postoperative functional capacity as assessed by a six-minute walk test and will minimize the incidence of postoperative complications. In addition, the investigator will also hypothesize that prehabilitation in the form of a multimodal approach (physical exercise, nutritional, pain, and neuroscience education) will increase the chances of discharge to home in the postoperative setting, and as a result will lead to a decrease overall healthcare expenditure and total costs.

Specific Aims:

  1. Does Multimodal Prehabilitation improve frail patients' preoperative functional capacity before spine surgery?
  2. Does Multimodal Prehabilitation improve frail patients' postoperative outcomes after spine surgery?
  3. Does Multimodal Prehabilitation improve frail patients' postoperative functional capacity after spine surgery?

The investigator will hypothesize that Multimodal Prehabilitation (physical, nutritional, and cognitive) improves frailty, functional capacity, and perioperative outcomes after spine surgery.

02

Conditions studied

  • Lumbar Spine Injury
  • Spinal Fusion
  • Frailty
  • Prehabilitation
  • Nutritional Supplementation
  • Functional Outcome

Keywords

  • Frailty
  • Prehabilitation
  • Perioperative Outcomes
03

In context

Spinal Injuries

57 studies on the registry are indexed under Spinal Injuries; 15 are open to participants now.

This study's enrollment of 10 is below the median of 52 across 31 interventional studies indexed under Spinal Injuries.

Browse Spinal Injuries studies →

Lead sponsor

University of Florida is the lead sponsor of 1,287 studies on the registry; 199 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Frailty score of 3 or more (based on Johns Hopkins Frailty Assessment).
  • Age 55 and older
  • Elective Lumbar or thoracolumbar Spine Fusion Surgery

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery
  • Time-sensitive surgery
  • Spine trauma, tumor, or infection
  • Physical condition that limits exercise: Lower extremity amputation, hemiplegia or hemiparesis, stroke with residual weakness, symptomatic severe cardiac disease (for example: severe aortic stenosis, unstable angina)
  • Patient refusal
  • Severe cognitive dysfunction preventing participation or consenting.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Multimodal Prehabilitation Arm

    The Multimodal Prehabilitation group will receive: * An exercise program focusing on aerobic exercise as well as strength training. Sessions will be supervised by a physical therapist, 2 times a week for a minimum of 6-8 weeks in addition to a home exercise program. Patients' compliance will be monitored by phone each week. * Protein supplements in the form of protein shakes at a dose of 1.2-1.5 gram per kg daily for 6-8 weeks. Protein supplements will be calculated based on ideal body weight and will be given to the patient with instructions on specific use. Diabetic patients will receive protein supplements that are sugar-free. * Pain and Neuroscience Education: Per University of Florida Health Pain and Neuroscience program at Shands hospital. * Standard Clinical Care: Preoperative medical optimization and management, referral to medical specialties as deemed necessary with a focus on preoperative cognitive assessment.

    Other: Multimodal Prehabilitation

  • Active comparator
    Standard Clinical Care Comparison Arm

    The Standard Clinical Care Comparison group will receive: * Education related to preoperative activity and home based exercise program. * Standard preoperative consultation with anesthesiology: Preoperative medical optimization and management, referral to medical specialties as deemed necessary with focus on preoperative cognitive assessment. * A final preoperative visit before surgery where a second set of functional assessment will be implemented

    Other: Standard Pre-Surgical Clinical Care

Interventions

  • OtherMultimodal Prehabilitation

    In addition to Standard Clinical Care Behavioral - An exercise program focusing on aerobic exercise as well as strength training. Sessions will be supervised by a physical therapist, 2 times a week for a minimum of 6-8 weeks in addition to home exercise program. They will also participate in a single session of Cognitive-Behavioral Therapy and will receive an educational pamphlet about Pain and Neuroscience Education. Dietary Supplement - Protein supplements in the form of protein shakes at a dose of 1.2-1.5 gram per kg daily for 6-8 weeks. Protein supplements will be calculated based on ideal body weight and will be given to the patient with instructions on specific use. Diabetic patients will receive protein supplements that are sugar free.

  • OtherStandard Pre-Surgical Clinical Care

    * Education related to preoperative activity and home-based exercise program. * Standard preoperative consultation with anesthesiology: Preoperative medical optimization and management, referral to medical specialties as deemed necessary with focus on preoperative cognitive assessment.

06

What researchers measure

Primary outcomes

  1. Frailty Assessment

    Johns Hopkins Frailty Assessment

    Time frame: Baseline up to 3 months

  2. 6 Minute Walk Test

    Distance and Percent Predicted Distance Travelled by Walking for 6 Minutes and then evaluating their performance in comparison to normal population. Also, measuring the the symptoms of fatigue and severity of dyspnea on exertion

    Time frame: Baseline up to 3 months

07

Study locations

1 site
  • UF Health of University of Florida
    Gainesville, Florida 32610, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2021 to primary completion in May 2024, 30 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2021
First posted
Sep 5, 2021
StartActual
Nov 1, 2021
Primary completionActual
May 8, 2024
CompletionActual
May 8, 2024
Last update
May 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05034341
Responsible party
Sponsor
First posted
Sep 5, 2021
Start date
Nov 1, 2021
Primary completion
May 8, 2024
Completion
May 8, 2024
Last update
May 13, 2024

Study contacts

Basma Mohamed, M.D.
principal investigator · University of Florida

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion